Cetirizine Hydrochloride
NDC 43598-183, Cetirizine Hydrochloride Tablets, tablet, film coated, from Dr. Reddy's Laboratories Inc..
- Product NDC
- 43598-183
- Status
- Listed
- Labeler
- Dr. Reddy's Laboratories Inc.
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- ANDA
- Application
- ANDA078343
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/43598-183 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CETIRIZINE HYDROCHLORIDE10 mg/1
Pharmacologic classes
Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 43598-183-31 | 43598018331 | 300 TABLET, FILM COATED in 1 BOTTLE (43598-183-31) |
| 43598-183-55 | 43598018355 | 500 TABLET, FILM COATED in 1 BOTTLE (43598-183-55) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 43598-183 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/43598-183 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 43598-183. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.